Email updates

Keep up to date with the latest news and content from BMC Anesthesiology and BioMed Central.

Open Access Research article

Prevalence and impact of alcohol and other drug use disorders on sedation and mechanical ventilation: a retrospective study

Marjolein de Wit12*, Sau Yin Wan3, Sujoy Gill1, Wendy I Jenvey12, Al M Best4, Judith Tomlinson5 and Michael F Weaver15

Author Affiliations

1 Virginia Commonwealth University, Department of Internal Medicine, Richmond, Virginia, USA

2 Virginia Commonwealth University, Division of Pulmonary and Critical Care Medicine, Richmond, Virginia, USA

3 University of Miami, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Miami, Florida, USA

4 Virginia Commonwealth University, Department of Biostatistics, Richmond, Virginia, USA

5 Virginia Commonwealth University, Department of Psychiatry, Division of Addiction Psychiatry, Richmond, Virginia, USA

For all author emails, please log on.

BMC Anesthesiology 2007, 7:3  doi:10.1186/1471-2253-7-3

Published: 14 March 2007

Abstract

Background

Experience suggests that patients with alcohol and other drug use disorders (AOD) are commonly cared for in our intensive care units (ICU's) and require more sedation. We sought to determine the impact of AOD on sedation requirement and mechanical ventilation (MV) duration.

Methods

Retrospective review of randomly selected records of adult patients undergoing MV in the medical ICU. Diagnoses of AOD were identified using strict criteria in Diagnostic and Statistical Manual of Mental Disorders, and through review of medical records and toxicology results.

Results

Of the 70 MV patients reviewed, 27 had AOD (39%). Implicated substances were alcohol in 22 patients, cocaine in 5, heroin in 2, opioids in 2, marijuana in 2. There was no difference between AOD and non-AOD patients in age, race, or reason for MV, but patients with AOD were more likely to be male (21 versus 15, p < 0.0001) and had a lower mean Acute Physiology and Chronic Health Evaluation II (22 versus 26, p = 0.048). While AOD patients received more lorazepam equivalents (0.5 versus 0.2 mg/kg.day, p = 0.004), morphine equivalents (0.5 versus 0.1 mg/kg.day, p = 0.03) and longer duration of infusions (16 versus 10 hours/day. medication, p = 0.002), they had similar sedation levels (Richmond Agitation-Sedation Scale (RASS) -2 versus -2, p = 0.83), incidence of agitation (RASS ≥ 3: 3.0% versus 2.4% of observations, p = 0.33), and duration of MV (3.6 versus 3.9 days, p = 0.89) as those without AOD.

Conclusion

The prevalence of AOD among medical ICU patients undergoing MV is high. Patients with AOD receive higher doses of sedation than their non-AOD counterparts to achieve similar RASS scores but do not undergo longer duration of MV.